Emory researchers offer a new perspective on the mechanism behind Alzheimer’s disease

Pieris Phar­ma­ceu­ti­cals is lay­ing off about 70% of its work­force in a “cor­po­rate re­struc­tur­ing” to pre­serve cash a lit­tle less than a month af­ter As­traZeneca

MADRID — Treatment with cemiplimab (Libtayo) followed by surgery showed encouraging survival rates in patients with resectable stage II-IV cutaneous squamous cell carcinoma (SCC), according